Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abortion, spontaneous
acquired immunodeficiency syndrome
adverse drug reaction
amaurosis fugax
ANA
ANA-negative systemic lupus erythematosus
anemia
anticardiolipin antibodies
anticoagulant, complications of
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulation effect
antineutrophil cytoplasmic autoantibodies
antiphospholipid antibodies
antiphospholipid antibody syndrome
apixaban
arteritis, temporal
arthralgia
ataxia
autoimmune disease
bedridden
Behcet's syndrome
birth injury
brainstem, infarction of
brodifacoum
CAT scan
CAT scan, abnormal
cerebellar hemorrhage
cerebral edema
cerebral embolism
cerebral embolism, cardiac origin
cerebral infarction
cerebral ischemia
cerebrospinal fluid, culture of, viral
cerebrospinal fluid, elevated protein of
cerebrovascular accident
cerebrovascular accident, recurrent
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, young adult
children
chorea
Clinical Pathologic Conference(C.P.C.)
coagulopathy
collagen vascular disease
coma
complications
Coombs test, positive
coumarin
C-reactive protein, elevated
cyanosis
cystic fibrosis, neurologic complications with
dabigatran
delivery, complicated
diarrhea
diplopia
disability, neurological
disseminated intravascular coagulation(DIC)
dysarthria
echocardiogram
edoxaban
embolism
encephalopathy
endocarditis
endocarditis, Libman-Sacks
endocarditis, marantic
epidemiology of neurology
epistaxis
factor Xa inhibitor
failure to thrive
false positive VDRL
fever
fibrinolytic agents
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic therapy, timing of administration
forceps delivery
Guillain Barre syndrome
head injury
head injury, pediatric
headache
headache, sudden onset of
hematemesis
hemodilution
hemophilia
hemorrhage, intracranial, newborn
hemorrhagic diathesis
hemorrhagic shock encephalopathy syndrome
heparin
hepatic failure
hetastarch
hirudin
hypocomplementemia
iatrogenic neurologic disorders
inclusion body myositis
intellectual deficit
intracerebral hemorrhage
intracranial hemorrhage
labor, complicated
livedo reticularis
lupus anticoagulant
Lyme disease
lymphadenitis
lymphocytic choriomeningitis
lymphopenia
malabsorption
malignant papulosis
meningitis
meningitis, aseptic
mental status, abnormal
metabolic acidosis
migraine
misdiagnosis
mitral valve lesion
mitral valve vegetation
mortality
MRI
MRI, abnormal
multiple sclerosis
multiple sclerosis, differential diagnosis of
multiple sclerosis, misdiagnosis
muscle pain
myelopathy
myocardial infarction
myocardial infarction, acute
nephritis
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neuropathology
neutropenia
non-vitamin K antagonist oral anticoagulants
non-vitamin K antagonist oral anticoagulants, coagulation test
nystagmus, vertical
obstetric neurologic injuries
partial thromboplastin time
partial thromboplastin time, prolonged
peripheral pulse, absent
peri-procedural
phenobarbital
pregnancy, neurologic complications in
prethrombotic state
prevention of neurologic disorders
prognosis
prothrombin time
prothrombin time, prolonged
pulmonary embolism
radial pulse, unilateral decrease of
rash
renal failure
retinal ischemia
review article
rivaroxaban
sedimentation rate, elevated
seizure
serologic testing
shock, hypovolemic
skin, hematoma
skin, lesions in neurologic disorders
subarachnoid hemorrhage
subdural hematoma
sweating
systemic illness
systemic lupus erythematosus
systemic lupus erythematosus, neurologic complications with
systemic lupus erythematosus, skin changes in
temporal artery, biopsy
thrombocytopenia
thrombophlebitis
thyroiditis
tissue plasminogen activator, intravenous
transient ischemic attack
transient neurologic deficit
treatment of neurologic disorder
vasculopathy
vasospasm, cerebral
Venereal Disease Research Laboratory test
venous thrombosis, non-cerebral
vertebral artery stenosis
vertebral-basilar insufficiency
viral infection
viral infection, CNS
viral isolation
visual loss
vitamin K
vitamin K deficiency
Western immunoblot test
white matter disease
Showing articles 2150 to 2200 of 5185 << Previous Next >>

Propofol and Thiopental for Refractory Status Epilepticus in Children
Neurol 65:591-592,506, van Gestel,J.P.J.,et al, 2005

Hyperglycemic Hemianopia: A Reversible Complication of Non-Ketotic Hyperglycemia
Neurol 65:616-619, Lavin,P.J.M., 2005

Phaeochromocytoma
Lancet 366:665-675, Lenders,J.W.M.,et al, 2005

Cerebral Vein and Dural Sinus Thrombosis in Elderly Patients
Stroke 36:1927-1932, Ferro,J.M.,et al, 2005

MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005

Respiratory Adverse Events Associated with Diazepam Rectal Gel
Neurol 64:1768-1770, Pellock,J.M. &Shinnar,S., 2005

Apoplexy in Pituitary Macroadenoma: Eight Patients Presenting in 12 Months
Medicine 84:188-196, Imboden,E.,e tal, 2005

HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcomes
Stroke 36:1298-1300, Moonis,M.,et al, 2005

Rabies Encephalomyelitis
Arch Neurol 62:873-882,855, Burton,E.C.,et al, 2005

NOA-03 Trial of High-Dose Methotrexate in Primary Central Nervous System Lymphoma:Final Report
Ann Neurol 57:843-847, Herrlinger,W.,et al, 2005

Body Fat Distribution and Long-Term Risk of Stroke Mortality
Stroke 36:1021-1025, Tanne,D.,et al, 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005

Ventriculoperitoneal Shunt in Patients with Leptomeningeal Metastasis
Neurol 64:1625-1627, Omuro,A.M.P.,et al, 2005

IV Thrombolysis in Patients with Acute Stroke Due to Spontaneous Carotid Dissection
Neurol 64:1612-1614, Georgiadis,D.,et al, 2005

Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances
Dept Health & Human Services (Apr), FDA Public Health Advisory, 2005

Fatal Toxic Leukoencephalopathy: Clinical, Radiological, and Necropsy Findings in Two Patients
JNNP 76:1014-1016, Ryan,A.,et al, 2005

Early Detection of Global Cerebral Anoxia:Improved Accuracy by High-b-Value Diffusion-Weighted Imaging with Long Echo Time
AJNR 26:1487-1497, Tha,K.K.,et al, 2005

Survival after Treatment of Rabies with Induction of Coma
NEJM 352:2508-2514,2549, Willoughby,Jr.,R.E.,et al, 2005

Four-Year Outcome after Early Withdrawal of Antiepileptic Drugs in Childhood Epilepsy
Neurol 64:2136-2138, Geerts,A.T.,et al, 2005

Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005

Time to Hospital Arrival, Use of Thrombolytics, and In-Hospital Outcomes in Ischemic Stroke
Neurol 64:2115-2120, Qureshi,A.I.,et al, 2005

Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Stroke 36:1512-1518, Wojner-Alexandrov,A.,et al, 2005

A Simple Score (ABCD) to Identify Individuals at High Early Risk of Stroke After Transient Ischaemic Attack
Lancet 366:29-36, Rothwell,P.M.,et al, 2005

Lymphocytic Choriomeningitis Virus Infection in Organ Transplant Recipients-Massachusetts, Rhode Island, 2005
MMWR 54:537-539, , 2005

Follow-Up of 89 Asymptomatic Patients with Adrenoleukodystrophy Treated with Lorenzos Oil
Arch Neurol 62:1073-1080,1045, Moser,H.W.,et al, 2005

Clinicopath Conf,Encephalomyelitis Due to West Nile Virus and CLL, Case 22-2005
NEJM 353:287-295, Hollande,H.,et al, 2005

Taste Disorders in Acute Stroke
Stroke 36:1690-1694, Heckmann, J.G.,et al, 2005

Spinal Cord Schistosomiasis: MR Imaging Appearance with Surgical and Pathologic Correlation
AJNR 26:1646-1654, Saleem,S.,et al, 2005

Pediatric Central Nervous System Posttransplant Lymphoproliferative Disorder
AJNR 26:1695-1697, Brennan,.C.,et al, 2005

Prognosis and Decision Making in Severe Stroke
JAMA 294:725-733, Holloway,R.G.,et al, 2005

Pure Monoparesis
Arch Neurol 62:1221-1224, Maeder-Ingvar,M.,et al, 2005

Marchiafava-Bignami Disease: Diffusion-Weighted MRI in Corpus Callosum and Cortical Lesions
Neurol 65:475-477, Mngon,P.,et al, 2005

Prognositc Implications of Right-Sided Insular Damage, Cardiac Autonomic Derangement, and Arrhythmias After Acute Ischemic Stroke
Stroke 36:1710-1715, Colivicchi,F.,et al, 2005

Causes and Predictors of Death in Cerebral Venous Thrombosis
Stroke 36:1720-1725, Canho,P.,et al, 2005

The Spectrum of Presentations of Venous Infarction Caused by Deep Cerebral Vein Thrombosis
Neurol 65:192-196, van den Bergh,W.M.,et al, 2005

Intermittent Prednisone Therapy in Duchenne Muscular Dystrophy
Arch Neurol 62:128-132, Beenakker,E.A.C.,et al, 2005

A 32-Year Prospective Study of Change in Body Weight and Incident Dementia
Arch Neurol 62:55-60,20, Stewart,R.,et al, 2005

Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005

Botulinum toxin injections in the treatment of musician's dystonia
Neurol 64:341-343, Schuele, S., et al, 2005

Musician's dystonia
Neurol 64:186-187, Pullman, S.L. & Hristova, A.H., 2005

Combined IV and intra-arterial thrombolysis for acute ischemic stroke
Neurol 64:386-388, Flaherty, M.L., et al, 2005

Efficacy of rapid IV administration of valproic acid for status epilepticus
Neurol 64:353-355, Limdi, N.A., et al, 2005

Do the Brain Attack Coalition's Criteria for Stroke Centers Improve Care for Ischemic Stroke?
Neurol 64:422-427, Douglas, V.C., et al, 2005

Is Optic Neuritis More Benign Than Other First Attacks in Multiple Sclerosis?
Ann Neurol 57:210-215, Tintore, M., et al, 2005

Ischaemic Stroke in Young Adults: Predictors of Outcome and Recurrence
JNNP 76:191-195, Nedeltchev, K., et al, 2005

A Fatal Encephalitis
Lancet 365:358, Schankin, C.J., et al, 2005

Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation
JAMA 293:427-436, The CREATE Trial Group Investigators, 2005

A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations
Arch Neurol 62:241-248, The PRESTO Study, 2005

Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005



Showing articles 2150 to 2200 of 5185 << Previous Next >>